A 59-Year-Old Woman With HER2+ De Novo Metastatic Breast Cancer
EP. 1: HER2+ De Novo Metastatic Breast Cancer Case Report
April 16th 2020
EP. 2: Recommendations for HER2 Testing in Metastatic Breast Cancer
April 16th 2020
EP. 3: Early Lines of Therapy for HER2+ De Novo Metastatic Breast Cancer
April 16th 2020
EP. 4: Selecting Third-Line Therapy to Treat HER2+ De Novo Metastatic Breast Cancer
April 16th 2020
EP. 5: HER2+ De Novo MBC: Neratinib Vs Lapatinib Plus Capecitabine
April 16th 2020
EP. 6: Neratinib Prophylaxis in HER2+ Metastatic Breast Cancer
April 16th 2020
